Chagas disease natural history, complications and prognosis

Jump to navigation Jump to search

Chagas disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chagas disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chagas disease natural history, complications and prognosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chagas disease natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chagas disease natural history, complications and prognosis

CDC on Chagas disease natural history, complications and prognosis

Chagas disease natural history, complications and prognosis in the news

Blogs on Chagas disease natural history, complications and prognosis

Directions to Hospitals Treating Chagas disease

Risk calculators and risk factors for Chagas disease natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The incubation period of T. cruzi is 1-2 weeks following transmission. Nonetheless, the majority (90%-95%) of infected individuals remain asymptomatic in the acute phase following Chagas disease infection. Nonetheless, the majority remain chronically infected and demonstrate clinical symptoms only after several years/decades of infection. Approximately 1/3 of patients develop manifestations of the chronic Chagas disease, namely cardiac conduction system dysfunction, GI denervation with esophageal and/or colonic dysfunction (megaesophagus and megacolon). Chagas cardiomyopathy is the most common chronic manifestation of the disease and accounts for approximately 80-90% of chronic manifestations. The majority of patients with Chagas cardiomyopathy die within 2 years of symptom onset.

Natural History

Acute Phase

  • The incubation period of T. cruzi is 1-2 weeks following transmission. Nonetheless, the majority (90%-95%) of infected individuals remain asymptomatic in the acute phase following Chagas disease infection.[1][2]
  • Some individuals may experience mild and non-specific clinical manifestations, such as fever, anorexia, and fatigue. These symptoms usually self-resolve within 4-8 weeks.[1]
  • Rarely, the acute phase of Chagas disease is life-threatening, and patients may present with either myocarditis of meningoencephalitis that require hospitalization.[1]

Asymptomatic (Indeterminate) Chronic Phase

  • The majority of patients are asymptomatic during the acute phase but remain chronically infected.[3]
  • Early during the chronic state, patients are asymptomatic.

Symptomatic Chronic Phase

  • Several years/decades following the initial acute phase, approximately 1/3 of patients develop manifestations of the chronic Chagas disease, namely cardiac conduction system dysfunction, GI denervation with esophageal and/or colonic dysfunction (megaesophagus and megacolon).[2]
  • Chagas cardiomyopathy is the most common chronic manifestation of the disease and accounts for approximately 80-90% of chronic manifestations. It is highly arrhythmogenic and often manifests with right bundle branch block, AV block, tachyarrhythmia/bradyarrhythmia. Patients typically progress to congestive heart failure and may develop thromboembolic events due to thrombus formation (often due to either dilation of the left ventricle or aneurysm formation). The majority of patients with Chagas cardiomyopathy die within 6 months - 2 years of onset of cardiac symptoms.[3]
  • Less commonly (10-20%), patients develop GI manifestations of chronic Chagas disease. Early esophageal Chagas disease often manifests with dysphagia, odynophagia, cough, reflux, and regurgitation. As the disease progresses, individuals experience significant weight loss and aspiration. Similarly, patients with colonic Chagas disease usually complain of constipation early in the disease that often progresses to development of fecaloma, volvolus, and ischemic bowel disease.[3]

Complications

Complications of Chagas disease include:[2][3][1]

Prognosis

  • Approximately 1/3 of chronically infected patients develop clinical manifestations of chronic Chagas disease.
  • Once Chagas cardiomyopathy becomes symptomatic, the prognosis is poor, and the majority of patients die within 6 months to 2 years following symptom onset.
  • Patients with HIV are at an increased rate of developing complications, even during the early phase of Chagas disease. HIV-positivity is associated with increased risk of Chagas myocarditis and meningoencephalitis.
  • The following index estimates the 10-year risk of Chagas disease-related mortality:[4]

Based on data from approximately 500 patients, this index incorporates individual information from the clinical aspects, X-ray findings, EKG, echocardiography and Holter.

Feature
Risk Factor Points
NYHA class III or IV 5
Cardiomegaly 5
Wall motion abnormalities 3
Non-sustained ventricular tachycardia 3
Low voltage on ECG 2
Male gender 2


Total Points 10-year Risk of Chagas Disease-related Mortality
0–6 10%
7–11 40%
12–20 85%

References

  1. 1.0 1.1 1.2 1.3 Bern C (2015). "Chagas' Disease". N Engl J Med. 373 (5): 456–66. doi:10.1056/NEJMra1410150. PMID 26222561.
  2. 2.0 2.1 2.2 Teixeira AR, Nitz N, Guimaro MC, Gomes C, Santos-Buch CA (2006). "Chagas disease". Postgrad Med J. 82 (974): 788–98. doi:10.1136/pgmj.2006.047357. PMC 2653922. PMID 17148699.
  3. 3.0 3.1 3.2 3.3 Prata A (1994). "Chagas' disease". Infect Dis Clin North Am. 8 (1): 61–76. PMID 8021449.
  4. Rassi A Jr, Rassi A, Little W, Xavier S, Rassi S, Rassi A, Rassi G, Hasslocher-Moreno A, Sousa A, Scanavacca M (2006). "Development and validation of a risk score for predicting death in Chagas' heart disease". N Engl J Med. 355 (8): 799–808. PMID 16928995.

Template:WH Template:WS